Catheter Precision, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Catheter Precision, Inc. (NYSE American: VTAK) on May 28, 2024. The filing discloses two material events: the execution of an Invention Assignment and Royalty Agreement and the creation of a short-term financial obligation via a related-party loan.
Key Financial Metrics and Obligations
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or margins for a reporting period. Instead, it details specific financial obligations:
- Related-Party Loan: The Company received a $500,000 loan from Executive Chair and CEO David A. Jenkins.
- Interest Rate: The loan bears interest at 8% per annum.
- Maturity Date: August 30, 2024.
- Royalty Commitments: The Company agreed to pay a 5% royalty on net sales of the LockeT device to co-inventor Auston Locke until $1 million is paid. If a patent is obtained, the rate drops to 2% until $10 million is paid. Payments cease after December 31, 2033, or upon patent expiration.
Material Changes and Related Party Transactions
The primary material change is the formalization of the royalty agreement with Auston Locke and the new debt obligation. The $500,000 note is a related-party transaction involving David A. Jenkins, who beneficially owns over 10% of the Company's common stock and holds rights to 11.77% of net sales royalties on the LockeT device. His daughter, Missiaen Huck, serves as the non-executive Chief Operating Officer.
Outlook, Risks, and Contingencies
The filing highlights specific risks associated with the new promissory note. The debt accelerates and becomes immediately due upon events of default, including failure to pay, material breach of representations, discontinuation of business, or insolvency proceedings. The royalty agreement is contingent on the successful acquisition of a U.S. patent for the LockeT device to trigger the reduced royalty rate structure.
Investor Verification Checklist
- Verify the Company's current cash position to assess its ability to repay the $500,000 note by August 30, 2024.
- Confirm the status of the U.S. Patent and Trademark Office application for the LockeT device, as this impacts future royalty rates.
- Review the "Certain Relationships and Related Party Transactions" section of the May 16, 2024 proxy statement for full disclosure on David A. Jenkins' holdings and influence.
- Monitor sales volume of the LockeT device to estimate the timeline for reaching the $1 million royalty cap.